EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Isolated Oral and Esophageal Mucosal Injury as a Rare Oxcarbazepine Adverse Drug Reaction: A Case Report

Joselyn De Jesus-Gonzalez, Quinten P Federico, Patrick Malafronte, Anne Champeaux, Shreya Narayanan, John Jacobs

Cureus · 27.09.2026

DOI: 10.7759/cureus.117018 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 27.09.2026. Verfasst von Joselyn De Jesus-Gonzalez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-induced mucosal injury may result from direct contact toxicity or immune-mediated adverse drug reactions. Although oxcarbazepine is a recognized etiology of severe hypersensitivity reactions, isolated oroesophageal mucosal injury without cutaneous or systemic involvement has not been previously described. We report a 68-year-old woman who developed severe diffuse esophagitis with concomitant oral mucosal ulceration approximately two weeks after oxcarbazepine initiation, with symptom onset within 24 hours of dose escalation from 150 to 300 mg twice daily. Histologic evaluation demonstrated predominantly lymphocytic esophageal inflammation with no evidence of infectious, eosinophilic, or immunobullous disease. The patient had no rash, peripheral eosinophilia, or systemic organ involvement. A Naranjo score of 7 supported a probable adverse drug reaction. Treatment consisted of discontinuation of oxcarbazepine alone, without the need for immunosuppressive or additional pharmacologic therapy. At five-month follow-up, the patient achieved endoscopic and histologic resolution. This case expands upon the recognized spectrum of oxcarbazepine-associated adverse drug reactions and emphasizes the importance of medication review in patients presenting with diffuse esophagitis and oral mucositis.

Schlagwörter

Stichwörter der Autor:innen

dysphagiamedication induced hypersensitivity reactionoral mucosal injuryoxcarbazepine adverse drug reactionsevere esophagitis

Autor:innen und Institutionen

  • Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, USA.
  • Department of Pathology and Laboratory Medicine, Tampa General Hospital, Tampa, USA.
  • Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, USA.
  • Division of Digestive Disease and Nutrition, Morsani College of Medicine, University of South Florida, Tampa, USA.
  • Division of Digestive Diseases and Nutrition, Joy McCann Culverhouse Center for Swallowing Disorders, Morsani College of Medicine, University of South Florida, Tampa, USA.

Zitieren

APA

De Jesus-Gonzalez, J., Federico, Q. P., Malafronte, P., Champeaux, A., Narayanan, S., & Jacobs, J. (2026). Isolated Oral and Esophageal Mucosal Injury as a Rare Oxcarbazepine Adverse Drug Reaction: A Case Report. Cureus. https://doi.org/10.7759/cureus.117018

Vancouver

De Jesus-Gonzalez J, Federico QP, Malafronte P, Champeaux A, Narayanan S, Jacobs J. Isolated Oral and Esophageal Mucosal Injury as a Rare Oxcarbazepine Adverse Drug Reaction: A Case Report. Cureus. 2026. doi:10.7759/cureus.117018

BibTeX
@article{DeJesusGonzalez2026,
  author = {De Jesus-Gonzalez, Joselyn and Federico, Quinten P and Malafronte, Patrick and Champeaux, Anne and Narayanan, Shreya and Jacobs, John},
  title = {Isolated Oral and Esophageal Mucosal Injury as a Rare Oxcarbazepine Adverse Drug Reaction: A Case Report},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.117018}
}
Kostenlos starten →